Abstract
The successes achieved in the treatment of melanomas through immunotherapy suggest what may be possible in the treatment of other tumors. Although immunotherapy had to prove itself at first in patients with widespread tumors late in the course of the disease, melanoma patients have more recently been referred for treatment with adjunctive immunotherapy shortly after removal of their primary tumor and/or involved lymph nodes. Even patients with disseminated disease have been seen earlier than in the past, often before any chemotherapy has been administered, because chemotherapy for melanoma has been notably unsuccessful in prolonging useful survival despite increases in the rates of response.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
